Today Ionis and Roche have announced more details from the Huntingtin lowering trial. The initial results was released in December […]
When the groundbreaking results of the Huntingtin lowering trial, IONIS-HTTRx, was announced the European Huntington Association travelled to Basel to […]
This December IONIS Pharmaceuticals announced their groundbreaking results from the first Huntingtin lowering trial in humans (called IONIS-HTTRx). At the […]
This date will probably go into history along with the discovery of the Huntington gene in 1993. Today IONIS Pharmaceuticals […]
Three times a year the EHDN newsletter appears. Now you can read the summer edition; with latest news from the […]
Three times a year the EHDN newsletter appears. Now you can read the Spring edition – with latest news from […]
It was 300 attendees at the World Orphan Drug Conference in Brussels from the 16th to 17th of November. Among them was the European Huntington Association’s President Astri Arnesen, the Board Members Svein Olaf Olsen and Bea De Schepper.
The European Huntington’s Disease Network (EHDN) is a nonprofit research network. EHDN forms a collaborative platform of scientists, clinicians, Huntington’s […]
In the Enroll-HD Newsletter of Autumn 2016 you can read current updates from the global Enroll-HD community. You will find […]
Follow Us
Funding Partners
